Cerebrotendinous xanthomatosis: Controversies about nerve and muscle: Observations in ten patients

Neuromuscular Disorders

Volumn 10, Issue 6, 2000, Pages 407-414

  Verrips, A ^a   Van Engelen, B G M ^a   Ter Laak, H ^a   Gabreels Festen A ^a   Janssen, A ^a   Zwarts, M ^a   Wevers, R A ^a   Gabreels F J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Axonal polyneuropathy; Cerebrotendinous xanthomatosis; Neuromuscular characteristics; Sural nerve

Indexed keywords

ADULT; ARTICLE; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL ARTICLE; ELECTROMYOGRAPHY; FEMALE; HUMAN; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; NERVE BIOPSY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SURAL NERVE;

ADULT; AXONS; BIOPSY; CYTOCHROME P-450 CYP27A1; CYTOCHROME P-450 ENZYME SYSTEM; ELECTROMYOGRAPHY; ELECTRON TRANSPORT; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; NERVE FIBERS; STEROID HYDROXYLASES; SURAL NERVE; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 0034255697     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(00)00112-7     Document Type: Article

References (56)

1. Oftebro H., Björkhem I., Stormer F.C., Pedersen J.I. Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors. J Lipid Res. 22:1981;632-640.
2. Björkhem I., Boberg K.M. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesteral. Scriver C., Beaudet A.L., Sly W.S., Valle D. The metabolic and molecular basis of inherited disease, 7th ed. 1995;2273-2299 McGraw-Hill, New York.
3. Wolthers B.G., Walrecht H.T., van der Molen J.C., Nagel G.T., Van Doormaal J.J., Wijnandts P.N. Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3 beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. J Lipid Res. 32:1991;603-612.
4. Wolthers B.G., Volmer M., van der Molen J., Koopman B.J., de Jager A.E., Waterreus R.J. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. Clin Chim Acta. 131:1983;53-65.
5. Amiel H., Gherardi R., Kanaan H.Y., et al. Cerebrotendinous xanthomatosis. Apropos of a case using magnetic resonance study of the brain and nerve biopsy. (Letter; in French) Ann Med Intern Paris. 140:1989;525-527.
6. Ben Hamida M., Chabbi N., Ben Hamida C., Mhiri C., Kallel R. Peripheral neuropathy in a sporadic case of cerebrotendinous xanthomatosis. (in French) Rev Neurol Paris. 147:1991;385-388.
7. Donaghy M., King R.H., McKeran R.O., Schwartz M.S., Thomas P.K. Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid. J Neurol. 237:1990;216-219.
8. Argov Z., Soffer D., Eisenberg S., Zimmerman Y. Chronic demyelinating peripheral neuropathy in cerebrotendinous xanthomatosis. Ann Neurol. 20:1986;89-91.
9. Katz D.A., Scheinberg L., Horoupian D.S., Salen G. Peripheral neuropathy in cerebrotendinous xanthomatosis. Arch Neurol. 42:1985;1008-1010.
10. Ohnishi A., Yamashita Y., Goto I., Kuroiwa Y., Murakami S., Ikeda M. De- and re-myelination and onion bulb in cerebrotendinous xanthomatosis. Acta Neuropathol (Berlin). 45:1979;43-45.
11. Voiculescu V., Alexianu M., Popescu Tismana G., Pastia M., Petrovici A., Dan A. Polyneuropathy with lipid deposits in Schwann cells and axonal degeneration in cerebrotendinous xanthomatosis. J Neurol Sci. 82:1987;89-99.
12. Pop P.H., Joosten E., van Spreeken A., et al. Neuroaxonal pathology of central and peripheral nervous systems in cerebrotendinous xanthomatosis (CTX). Acta Neuropathol (Berlin). 64:1984;259-264.
13. Soffer D., Benharroch D., Berginer V. The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature. Acta Neuropathol. 90:1995;213-220.
14. Dotti M.T., Manneschi L., Federico A. Mitochondrial enzyme deficiency in cerebrotendinous xanthomatosis. J Neurol Sci. 129:1995;106-108.
15. Federico A., Dotti M.T., Volpi N. Muscle mitochondrial changes in cerebrotendinous xanthomatosis. Ann Neurol. 30:1991;734-735.
16. van Hellenberg Hubar J.L., Joosten E.M., Wevers R.A. Cerebrotendinous xanthomatosis. Clin Neurol Neurosurg. 94(Suppl):1992;S165-S167.
17. Cruysberg J.R., Wevers R.A., Engelen B.G.M., Pinckers A., Spreeken A., Tolboom J.J. Ocular and systemic manifestations of cerebrotendinous xanthomatosis. Am J Ophthalmol. 120:1995;597-604.
18. Waterreus R.J., Koopman B.J., Wolthers B.G., Oosterhuis H.J. Cerebrotendinous xanthomatosis (CTX): a clinical survey of the patient population in the Netherlands. Clin Neurol Neurosurg. 89:1987;169-175.
19. Wevers R.A., Cruysberg J.R., Van Heijst A.F., et al. Paediatric cerebrotendinous xanthomatosis. J Inherit Metab Dis. 15:1992;374-376.
20. Dormans T., Verrips A., Bulten J., Cox N. Pulmonary lymphangioleiomyomatosis and cerebrotendinous xanthomatosis: is there a link? Chest. 112:1997;273-274.
21. Luyten J.A.F.M., Wenink P.W., Steenbergen-Spanjers G.C.H., et al. Metachromatic leukodystrophy: a 12-bp deletion in exon 2 of the arylsulfatase A gene in the late infantile variant. Hum Genet. 96:1995;357-360.
22. Verrips A., Steenbergen-Spanjers G.C.H., Luyten J.A.F.M., et al. Two new mutations in the sterol 27-hydroxylase gene in two families lead to cerebrotendinous xanthomatosis. Hum Genet. 98:1996;735-737.
23. Fischer J.C., Ruitenbeek W., Gabreëls F.J.M., et al. A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Paediatr. 144:1986;441-444.
24. Stadhouders A.M., Jap P.H.K., Winkler H.P., Eppenberger H.M., Walliman T. Mitochondrial creatine kinase: a major constituent of pathological inclusions seen in mitochondrial myopathies. Proc Natl Acad Sci USA. 91:1994;5089-5093.
25. Meiner V., Meiner Z., Reshef A., Björkhem I., Leitersdorf E. Cerebrotendinous xanthomatosis: molecular diagnosis enables presymptomatic detection of a treatable disease. Neurology. 44:1994;288-290.
26. Reshef A., Meiner V., Berginer V.M., Leitersdorf E. Molecular genetics of cerebrotendinous xanthomatosis in Jews of North African origin. J Lipid Res. 35:1994;478-483.
27. Cali J.J., Hsieh C.L., Francke U., Russell D.W. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem. 266:1991;7779-7783.
28. Garuti R., Lelli N., Barozzini M., et al. Cerebrotendinous xanthomatosis caused by two new mutations of the sterol-27-hydroxylase gene that disrupt mRNA splicing. J Lipid Res. 37:1996;1459-1467.
29. Diedrich U., Ropte S. Cerebrotendinous xanthomatosis: description of two cases and differential diagnosis in relation to encephalomyelitis disseminata. (in German) Nervenarzt. 60:1989;444-447.
30. Elleder M., Michalec C., Jirasek A., Khun K., Havlova M., Ranny M. Membranocystic lesion in the brain in cerebrotendinous xanthomatosis. Histochemical and ultrastructural study with evidence of its ceroid nature. Virchows Arch B Cell Pathol. 57:1989;367-374.
31. Bogaert L., Scherer H., Epstein E. Une forme cérébrale de la cholestérinose généralisée. 1937;Masson, Paris.
32. Guillain G., Bertrand I., Godet-Guillain M. A clinical and pathologic investigation of a case with cerebral cholesterinosis. (in French) Rev Neurol. 74:1942;248-263.
33. Philippart M., Van Bogaert L. Cholestanolosis (cerebrotendinous xanthomatosis). A follow-up study on the original family. Arch Neurol. 21:1969;603-610.
34. Schimschock J.R., Alvord E.C.J., Swanson P.D. Cerebrotendinous xanthomatosis. Clinical and pathological studies. Arch Neurol. 18:1968;688-698.
35. Berginer V.M., Salen G., Shefer S. Cerebrotendinous xanthomatosis. Neurol Clin. 7:1989;55-74.
36. Watts G., Mitchell W., Bending J., Reshef A., Leitersdorf E. Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherapy. Q J Med. 89:1996;55-63.
37. Meiner V., Marais D.A., Reshef A., Björkhem I., Leitersdorf E. Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in an Afrikaner family. Hum Mol Genet. 3:1994;193-194.
38. Segev H., Reshef A., Clavey V., Delbart C., Routier G., Leitersdorf E. Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in a French family. Hum Genet. 95:1995;238-240.
39. Prayson R.A., Cohen M.L. Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis. Hum Pathol. 28:1997;887-892.
40. Wong K.T., Dick D., Anderson J.R. Mitochondrial abnormalities in oculopharyngeal muscular dystrophy. Neuromusc Disord. 6:1996;163-166.
41. Hammersen F., Gidlof A., Larsson J., Lewis D.H. The occurrence of paracrystalline mitochondrial inclusions in normal human skeletal muscle. Acta Neuropathol (Berlin). 49:1980;35-41.
42. Marbini A., Gemignani F., Bragaglia M.M., Govoni E. Mitochondrial paracrystalline inclusions in the peroneus brevis muscle of patients with peripheral neuropathy. Clin Neuropathol. 6:1987;38-42.
43. Morgan Hughes J.A. Tubular aggregates in skeletal muscle: their functional significance and mechanisms of pathogenesis. (Editorial) Curr Opin Neurol. 11:1998;439-442.
44. Bradley W.G., Taylor R., Rice D.R., et al. Progressive myopathy in hyperkalemic periodic paralysis. Arch Neurol. 47:1990;1013-1017.
45. Martin J.J., Ceuterick C., Van Goethem G. On a dominantly inherited myopathy with tubular aggregates. Neuromusc Disord. 7:1997;512-520.
46. Cameron C.H., Allen I.V., Patterson V., Avaria M.A. Dominantly inherited tubular aggregate myopathy. J Pathol. 168:1992;397-403.
47. Figarella Branger D., Pellissier J.F., Perez Castillo A.M., Desnuelle C., Pouget J., Serratrice G. Slowly progressive myopathy with accumulation of tubular aggregates. (in French) Rev Neurol Paris. 147:1991;586-594.
48. Valtonen M., Nanto Salonen K, Heinanen K, Alanen A, Kalimo H, Simell O. Skeletal muscle of patients with gyrate atrophy of the choroid and retina and hyperornithinaemia in ultralow-field magnetic resonance imaging and computed tomography. J Inherit Metab Dis. 19:1996;729-734.
49. Rosenberg N.L., Neville H.E., Ringel S.P. Tubular aggregates. Their association with neuromuscular diseases, including the syndrome of myalgias/cramps. Arch Neurol. 42:1985;973-976.
50. Del Villar Negro A., Merino Angulo J., Rivera Pomar J.M. Skeletal muscle changes in chronic alcoholic patients. A conventional, histochemical, ultrastructural and morphometric study. Acta Neurol Scand. 70:1984;185-196.
51. Del Villar Negro A., Merino Angulo J., Rivera Pomar J.M., Aguirre Errasti C. Tubular aggregates in skeletal muscle of chronic alcoholic patients. Acta Neuropathol (Berlin). 56:1982;250-254.
52. Doriguzzi C., Mongini T., Jeantet A., Monga G. Tubular aggregates in a case of osteomalacic myopathy due to anticonvulsant drugs. Clin Neuropathol. 3:1984;42-45.
53. Carvalho M.S., Lusvarghi E.S., Levy A.L., Salum P.N., Rodrigues C.J., Levy J.A. Myopathies associated with tubular aggregates. (in Spanish) Arq Neuro-Psiquiatr. 51:1993;363-370.
54. Dyck P.J., Lais A.G., Karnes J.L., et al. Permanent axotomy, a model of axonal atrophy and secondary segmental demyelination and remyelination. Ann Neurol. 9:1981;575-583.
55. Antonarakis S.E. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat. 11:1998;1-3.
56. Dyck P.J. Pathologic alterations of the peripheral nervous system of man. Dyck P.J., Thomas P.K., Lambert E.H. Peripheral neuropathy. 1975;296-336 W.B. Saunders, Philadelphia, PA.